Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
6-O-desulfated enoxaparin
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/10/2020
6-O-desulfated unfranctionated heparin
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/10/2020
Inactivated SARS-CoV-2 vaccine
Potential treatment - clinical evidence Experimental Vaccine Nov/09/2020
TRS-1 PPMO
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/09/2020
5'END-1 PPMO
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/09/2020
5'END-2 PPMO
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/09/2020
TRS-2 PPMO
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/09/2020
Sophaline D
Potential treatment - theoretical effect Natural product Antiviral Nov/09/2020
Thalimonine
Potential treatment - theoretical effect Natural product Antiviral Nov/09/2020
Interferon beta-1b
Potential treatment - clinical evidence Used to treat other disease Antiviral Nov/09/2020
Propolis alcohol extract
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/07/2020
ABP-700
Potential treatment - theoretical effect Experimental Antiviral Nov/06/2020
Amobarbital
Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/06/2020
Stavudine
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/06/2020
Raltegravir
Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/06/2020
Melatonin
Potential treatment - theoretical effect Natural product Antiviral Nov/06/2020
mNb6-tri
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/05/2020
CTC-445.2d
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/05/2020
CTC-445.2
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/05/2020
Naldemedine
Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/05/2020